Epothilone glycoside compounds having structures shown in formula (I) or (II), and pharmaceutical compositions containing an effective amount of the epothilone glycoside compounds and pharmaceutically acceptable carriers, which can be used for preventing and treating liver cancer, lung cancer and breast cancer.